Event Abstract Back to Event Biomimetic interfaces to trigger tissue restoration Ennio Tasciotti1, Francesca Taraballi1, Alessandro Parodi1, Jonathan O. Martinez1, Silvia Minardi1, Naama E. Toledano Furman1, Roberto Molinaro1, Fernando Cabrera1, Laura Pandolfi1, Bruna Corradetti1, Ciro Chiappini1, Jeffrey Van Eps1, Anna Tampieri1 and Bradley K. Weiner1 1 Houston Methodist Research Institute, Regenerative Medicine, United States Introduction: Cells interact and locally interface with the surrounding environment at the macroscale (whole organ), microscale (tissue), and nanoscale (extracellular matrix). Advances in micro and nano-engineering allow the synthesis of materials with features that allow to control and direct cell behavior at multiple scales. By tuning the physical, chemical and biological properties of the materials to match those of native tissues and of cellular processes, we generated biomimetic platforms able to overcome the biological barriers involved in drug delivery and tissue repair. By using the design principles of biomimicry, we exploited the nano-bio interface as a way to negotiate the restoration of tissues function. Materials and Methods: We developed two main classes of biomimetic materials: implantables and injectables. In both cases we applied fabrication strategies based on use of biomaterials able to mimic the material-cell interface for composition, architecture, function, assembly, and biochemical environment. In fact, in the synthesis of our multi-functional platforms was performed using exclusively the components typically found in the body: cellular membranes, proteins, or natural extracellular components (minerals and sugars). Results and Discussion: To overcome the barriers encountered during systemic administration, we developed a drug delivery system comprised of purified leukocyte membranes grafted onto the surface of a biodegradable core (i.e., leuko-like vectors, LLV). The proteolipid material transferred to LLV functioned as a biomimetic camouflage that allowed the inhibition of opsonization and reticulo-endothelial internalization; promoted the increased adherence to inflamed vasculature (Fig 1A), and the activation of intracellular pathways that resulted in the avoidance of endolysosomal entrapment and an increase in vascular permeability (Fig 1B)[1]. To gain access to the cytosol and increase the delivery of biologically labile payloads (nucleic acids), we developed biodegradable nanoneedles capable of directing interfacing with the cytosol through the penetration of the cellular membrane (i.e., nanoinjection). This nano-bio interface did not induce any toxic response in the cell by prompting the rearrangement of the nuclear and plasma membrane (Fig 1C,D)[2],[3], and allowed the in vivo delivery of genes to locally trigger increased neovascularization2 (Fig 1E-G). In tissue regeneration we widely exploited the idea of actively targeting the stem cell niche using different routes. We mimicked the regenerative niche in pore size, stiffness and overall architecture (Fig 2 A, B, C)[4]. Using nanoengineering, we tuned the release profiles of the embedded growth factors to control their local concentration to resemble the kinetics observed in physiological conditions (Fig 2 D, E, F, H)[5],[6]. All these strategies were successfully applied to functionally regenerate both hard and soft tissues. Conclusion: Biomimetic nanomaterials represent a powerful solution to interact with cells and guide their ultimate fate. By engineering surfaces to bestow them with the ability to instruct cells towards a regenerative outcome we achieved superior functional recovery and therapeutic outcome through the activation of the natural processes of cell and tissue healing.
Read full abstract